insights_auto
Why is STIM down 5.03%?
Dive Deeperchevron_right
STIM:NASDAQ
Neuronetics Inc
$1.89
arrow_downward
-5.03%(-0.10) 1D
Oct 14, 11:50:10 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$1.95
High
$1.97
Low
$1.88
Mkt. cap
144.01M
Avg. vol.
1.12M
Volume
403.28K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
Open
$1.95
High
$1.97
Low
$1.88
Mkt. cap
144.01M
Avg. vol.
1.12M
Volume
403.28K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
Investing News Network
·
10 minutes ago
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
The Arkansas Democrat-Gazette
·
17 minutes ago
Little Rock based BSR Real Estate Investment Trust shares trading on the New York Stock Exchange
Reuters
·
2 hours ago
Wall St opens lower after hot CPI data fuels rate-hike bets
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com